Latane what is your take on NP I think everyone here believes in Leronlimab however many feel that our CEO is the reason for our lack of approval. I’m not sure if it’s NP or just the FDA making it difficult. It doesn’t make sense that the 2 drugs approved for HIV are less than 50% efficacy with bad side effects. While our drug is over 80% with no side effects. That’s not on the CEO . The entire 350 vs 700 mg dose is a complete delay tactic by the FDA.
Now let’s look at NP. To many pointless CC’s on a third world broadcast station. Rarely if ever meets a timeline. Trying to pay himself in advance for a job not complete. Not well spoken and difficult to understand. Failure to get enough attention or mainstream media to shed light on a remarkable drug. Failure to put pressure on the FDA to approve Leronlimab . Granted we wouldn’t be having this conversation if not for NP . The question remains has he taken us as far as he can.
I have this question many times is it time for him to go and if so how does that ball start moving. I don’t think we have any control over that process , do we? How many of you on this board think NP is the problem or is it the FDA. Maybe it’s a combination of the two.
Any and all who would like to weigh in on this please feel free . As for me I’m not sure what I think the problem is anymore . It is very frustrating to have a drug like ours and to have it sidelined as a pandemic unfolds right in front of us.
Market Data 
Markets 
AI
